◀ Back to E2F1
CCNE1 — E2F1
Pathways - manually collected, often from reviews:
-
OpenBEL Selventa BEL large corpus:
Complex of CCNE1-CDK2
→
E2F1
(increases, CCNE1/CDK2 Activity)
Hartman et al., Oncogene 2004*
Evidence: Expression of HES-1 in T47D cells inhibited G(1)/S-phase transition and activation of Cdk2 elicited by estrogen.
-
BioCarta cell cycle: g1/s check point:
RB/HDAC/ABL/E2F-1/DP-1 complex (E2F1-RB1-TFDP1-ABL1-HDAC1)
→
Cyclin E/CDK2 complex (CCNE1-CDK2)
(modification, collaborate)
-
BioCarta cell cycle: g1/s check point:
Cyclin E/CDK2 complex (CCNE1-CDK2)
→
E2F-1/DP-1 complex (TFDP1-E2F1)
(modification, activates)
-
BioCarta e2f1 destruction pathway:
RB/E2F-1 complex (E2F1-RB1)
→
Cyclin E/CDK2 complex (CCNE1-CDK2)
(modification, collaborate)
-
BioCarta e2f1 destruction pathway:
Cyclin E/CDK2 complex (CCNE1-CDK2)
→
E2F-1 (E2F1)
(modification, activates)
-
BioCarta p53 signaling pathway:
RB/E2F-1 complex (E2F1-RB1)
→
CDK2/CYCLIN E/PCNA complex (CDK2-CCNE1-PCNA)
(modification, collaborate)
-
BioCarta regulation of p27 phosphorylation during cell cycle progression:
E2F-1/DP-1 complex (TFDP1-E2F1)
→
Cyclin E (CCNE1)
(transcription, activates)
-
BioCarta influence of ras and rho proteins on g1 to s transition:
RB/E2F-1 complex (E2F1-RB1)
→
Cyclin E/CDK2 complex (CCNE1-CDK2)
(modification, collaborate)
-
BioCarta cyclins and cell cycle regulation:
RB/E2F-1 complex (E2F1-RB1)
→
Cyclin E/CDK2 complex (CCNE1-CDK2)
(modification, collaborate)
-
BioCarta cell cycle: g1/s check point:
E2F-1/DP-1 complex (TFDP1-E2F1)
→
Cyclin E (CCNE1)
(transcription, activates)
-
KEGG Cell cycle:
Complex of E2F1-E2F2-E2F3-TFDP1-TFDP2
→
CCNE1/CCNE2
(gene expression, expression)
-
NCI Pathway Database Regulation of retinoblastoma protein:
CDK2/Cyclin E1 complex (CDK2-CCNE1)
→
RB1/E2F1-3/DP complex (RB1-E2F3_E2F2_E2F1-TFDP1)
(modification, activates)
Harbour et al., Cell 1999, Chan et al., Nat Cell Biol 2001, Rubin et al., Cell 2005
Evidence: mutant phenotype, assay, reporter gene, physical interaction
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Suzuki et al., Int J Cancer 2000
(Mouth Neoplasms...) :
TSA
enhanced the protein expression of p21 ( WAF1 ), CREB binding protein,
cyclinE , cyclin A, Bak and Bax, while it reduced the expression of
E2F-1 , E2F-4, HDAC1, p53 and hyperphosphorylated form of Rb
El Messaoudi et al., Proc Natl Acad Sci U S A 2006
:
E2F dependent regulation of the
CCNE1 promoter was shown to correlate with changes in the level of H3-K9 acetylation/methylation of nucleosomal histones positioned at the transcriptional start site region
Duronio et al., Genes Dev 1995
:
Instead,
cyclin E expression
activates E2F in the CNS
Chiarugi et al., Cell Mol Biol Res 1994
:
Notably, both of the two giant regulators of checkpoint 1 ( i.e., p105RB [ retinoblastoma oncosuppressor encoded protein ] and p53 dependent WAF1/CIP1 ) are influenced by or influence G1 cyclins :
cyclin E/cdk2 kinase complexes hyperphosphorylate p105RB,
induce E2F release, and free G1 exit